KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 259 filers reported holding KARUNA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.43 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $964 | -12.8% | 5,700 | +11.8% | 0.01% | -16.7% |
| Q2 2023 | $1,106 | +60.3% | 5,100 | +34.2% | 0.01% | +50.0% |
| Q1 2023 | $690 | -7.6% | 3,800 | 0.0% | 0.00% | -20.0% |
| Q4 2022 | $747 | -99.9% | 3,800 | 0.0% | 0.01% | -16.7% |
| Q3 2022 | $855,000 | +98.8% | 3,800 | +11.8% | 0.01% | +100.0% |
| Q2 2022 | $430,000 | -0.2% | 3,400 | 0.0% | 0.00% | +50.0% |
| Q1 2022 | $431,000 | -37.9% | 3,400 | -35.8% | 0.00% | -33.3% |
| Q4 2021 | $694,000 | +1.3% | 5,300 | -5.4% | 0.00% | -25.0% |
| Q3 2021 | $685,000 | +39.8% | 5,600 | +30.2% | 0.00% | +33.3% |
| Q2 2021 | $490,000 | +10.1% | 4,300 | +16.2% | 0.00% | 0.0% |
| Q1 2021 | $445,000 | +18.4% | 3,700 | 0.0% | 0.00% | +50.0% |
| Q4 2020 | $376,000 | -23.3% | 3,700 | -15.9% | 0.00% | 0.0% |
| Q2 2020 | $490,000 | – | 4,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 908,708 | $109,254,000 | 35.05% |
| Sofinnova Investments, Inc. | 1,952,441 | $234,742,000 | 14.11% |
| Logos Global Management LP | 200,000 | $24,046,000 | 2.35% |
| First Light Asset Management, LLC | 258,500 | $31,079,000 | 2.06% |
| Eventide Asset Management | 971,077 | $116,753,000 | 1.73% |
| DAFNA Capital Management LLC | 48,000 | $5,771,000 | 1.37% |
| CATALYST PRIVATE WEALTH, LLC | 13,006 | $1,564,000 | 1.10% |
| Rock Springs Capital Management LP | 368,764 | $44,336,000 | 0.97% |
| Pinz Capital Management, LP | 28,805 | $3,463,000 | 0.92% |
| MILLER VALUE PARTNERS, LLC | 291,239 | $35,016,000 | 0.91% |